Indrabati Lahiri
Business
Bayer reaps benefits of demand for new cancer and kidney medicines
German pharmaceutical giant Bayer AG released its second quarter and half year 2024 earnings on Tuesday morning, with the company seeing an average performance in the second quarter, due to the agricultural market environment becoming tougher.
Business
Intel unveils plans to axe 15% of workforce in cost saving initiative
The company also issued a revenue warning for the third quarter of the year, revealing that it was planning to focus more on artificial intelligence semiconductors, instead of traditional data centre ones in the coming months.